Projects per year
Fingerprint
Dive into the research topics where Wilson Gonsalves is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies
3/1/21 → 2/29/24
Project: Research project
-
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma
7/1/17 → 6/30/20
Project: Research project
-
An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
Alodhaibi, I., Ailawadhi, S., Burbano, G. P., O'Brien, P. J., Buadi, F. K., Hayman, S., Kumar, S. K. & Gonsalves, W. I., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review
-
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma
Goldman-Mazur, S., Visram, A., Rajkumar, S. V., Kapoor, P., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Hayman, S. R., Dingli, D., Kourelis, T., Gonsalves, W., Warsame, R., Muchtar, E., Leung, N., Kyle, R. A. & Kumar, S. K., Mar 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 3, p. e104-e111.e1Research output: Contribution to journal › Article › peer-review
-
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)
Visram, A., Hayman, S. R., Dispenzieri, A., Kapoor, P., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Dingli, D., Warsame, R., Kourelis, T., Cook, J., Binder, M., Gonsalves, W., Muchtar, E., Leung, N., Roy, V., Rajkumar, S. V. & Kumar, S., Aug 2023, In: American journal of hematology. 98, 8, p. 1277-1285 9 p.Research output: Contribution to journal › Article › peer-review
-
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hayman, S., Kourelis, T., Warsame, R., Hwa, Y., Fonder, A., Hobbs, M., Muchtar, E., Leung, N., Kapoor, P., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., & 2 others , Dec 2023, In: Blood cancer journal. 13, 1, 91.Research output: Contribution to journal › Letter › peer-review
Open Access -
Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma
Goel, U., Charalampous, C., Kapoor, P., Binder, M., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonder, A., Gertz, M. A., Gonsalves, W. I., Hayman, S. R., Hobbs, M. A., Hwa, Y. L., Kourelis, T., Lacy, M. Q., Leung, N., Lin, Y., Warsame, R. M., Kyle, R. A., Rajkumar, S. V., & 1 others , Dec 2023, In: Blood cancer journal. 13, 1, 11.Research output: Contribution to journal › Letter › peer-review
Open Access